Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation

被引:59
作者
Grady, Kathleen L. [1 ]
Naftel, David [2 ]
Stevenson, Lynne [3 ]
Dew, Mary Amanda [4 ,5 ,6 ,7 ]
Weidner, Gerdi [8 ]
Pagani, Francis D. [9 ]
Kirklin, James K. [2 ]
Myers, Susan [2 ]
Baldwin, Timothy [10 ]
Young, James [11 ]
机构
[1] Northwestern Univ, Div Cardiac Surg, Dept Surg, Chicago, IL 60611 USA
[2] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA
[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[4] Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Sch Med, Dept Biostat, Pittsburgh, PA USA
[6] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA
[7] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[8] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA
[9] Univ Michigan, Ctr Circulatory Support, Ann Arbor, MI 48109 USA
[10] NHLBI, Bethesda, MD 20892 USA
[11] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
mechanical circulatory support; health-related quality of life; heart failure; INTERMACS; continuous-flow pump; VENTRICULAR ASSIST DEVICE; INTERMACS ANNUAL-REPORT; DESTINATION THERAPY; HEALTH-STATUS; EQ-5D; OUTCOMES; SURVIVAL; IMPACT;
D O I
10.1016/j.healun.2013.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The severity of pre-implantation heart failure may affect post-implantation health-related quality of life (HRQOL). The purpose of our study was to examine differences in HRQOL from before mechanical circulatory support (MCS) through 1 year after surgery by Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) patient profiles. METHODS: Data from 1,559 adults with advanced heart failure who received primary continuous-flow pumps between June 23, 2006, and March 31, 2010, and were enrolled in INTERMACS were analyzed. IARQOL data were collected using the EQ-5D-3L survey before implantation and at 3, 6, and 12 months after implantation. Statistical analyses included chi-square and t-tests, using all available data for each time period. Paired t-tests and sensitivity analyses were also conducted. RESULTS: HRQOL was poor before MCS implantation among patients with INTERMACS profiles 1 to 7 and significantly improved after MCS implantation for all profiles. Stratified by INTERMACS profile, problems within each of the 5 dimensions of HRQOL (i.e., mobility, self-care, usual activities, pain, and anxiety/depression) generally decreased from before to after implantation. By 6 months after implantation, patients with all INTERMACS profiles reported similar frequencies of problems for all HRQOL dimensions. Paired t-tests and sensitivity analyses supported almost all of our findings. CONCLUSIONS: HRQOL is poor among advanced heart failure patients with INTERMACS profiles 1 to 7 before MCS implantation and improves to similar levels for patients who remained on MCS 1 year after surgery. Patients have problems in HRQOL dimensions before and after MCS; however, the frequency of reporting problems decreases for all dimensions within most profiles across time. (C) 2014 International Society for Heart and Lung Tiansplantation. All rights reserved.
引用
收藏
页码:412 / 421
页数:10
相关论文
共 28 条
[1]   Executive Summary: Decision Making in Advanced Heart Failure A Scientific Statement From the American Heart Association [J].
Allen, Larry A. ;
Stevenson, Lynne W. ;
Grady, Kathleen L. ;
Goldstein, Nathan E. ;
Matlock, Daniel D. ;
Arnold, Robert M. ;
Cook, Nancy R. ;
Felker, G. Michael ;
Francis, Gary S. ;
Hauptman, Paul J. ;
Havranek, Edward P. ;
Krumholz, Harlan M. ;
Mancini, Donna ;
Riegel, Barbara ;
Spertus, John A. .
CIRCULATION, 2012, 125 (15) :1-2
[2]   Study on health-related quality of life in patients with advanced heart failure before and after transplantation [J].
Almenar-Pertejo, M. ;
Almenar, L. ;
Martinez-Dolz, L. ;
Campos, J. ;
Galan, J. ;
Girones, P. ;
Ortega, F. ;
Ortega, T. ;
Rebollo, P. ;
Salvador, A. .
TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) :2524-2526
[3]   NHLBI's Program for VAD Therapy for Moderately Advanced Heart Failure: The REVIVE-IT Pilot Trial [J].
Baldwin, J. Timothy ;
Mann, Douglas L. .
JOURNAL OF CARDIAC FAILURE, 2010, 16 (11) :855-858
[4]   Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification [J].
Boyle, Andrew J. ;
Ascheim, Deborah D. ;
Russo, Mark J. ;
Kormos, Robert L. ;
John, Ranjit ;
Naka, Yoshifumi ;
Gelijns, Annetine C. ;
Hong, Kimberly N. ;
Teuteberg, Jeffrey J. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04) :402-407
[5]  
Braunwald Eugene., 2005, Braunwald's Heart disease, Text book Cardiovascular Medicine Disease, V7th Edn
[6]   The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study [J].
Calvert, MJ ;
Freemantle, N ;
Cleland, JGF .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (02) :243-251
[7]   A review of health utilities using the EQ-5D in studies of cardiovascular disease [J].
Dyer, Matthew T. D. ;
Goldsmith, Kimberley A. ;
Sharples, Linda S. ;
Buxton, Martin J. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2010, 8
[8]  
Field M.J., 1997, Approaching death: Improving care at the end of life
[9]  
Grady K L, 1998, Am J Crit Care, V7, P106
[10]   Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation [J].
Grady, KL ;
Meyer, PM ;
Dressler, D ;
Mattea, A ;
Chillcott, S ;
Loo, A ;
White-Williams, C ;
Todd, B ;
Ormaza, S ;
Kaan, A ;
Costanzo, MR ;
Piccione, W .
ANNALS OF THORACIC SURGERY, 2004, 77 (04) :1321-1327